BioSpace News Archive

SciSparc Ltd. today announced that Clearmind Medicine Inc. (“Clearmind”) (CSE: CMND), (OTC: CMNDF), (FSE: CWY0), has filed a provisional patent application related to metabolic syndromes including obesity, regarding the Company’s collaboration with Clearmind.

Ocean Biomedical and Aesther Healthcare Acquisition Corp. (“Aesther”) (NASDAQ: AEHA) recently announced business combination, once closed, will further Ocean Biomedical’s work on the discovery of a whole new class of antimalarial drugswhich target PfGARP and kill malaria parasites.

Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that members of management will participate in a fireside chat at the Ladenburg Thalmann Healthcare Conference on Thursday, September 29 at 12:30 p.m. E.T.

Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova”), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, today announced that the Company will be participating in-person in the Ladenburg Thalmann 2022 Healthcare Conference, which is taking place at the Sofitel Hotel in New York, NY.

Avid Bioservices, Inc. today announced the appointment of Michael Alston, Jr. as vice president, operations.

Regenative Labs, a leading HCT/P manufacturer, has authored a peer-reviewed case study outlining the benefits of dehydrated amniotic membrane allografts (DAMA) in the treatment of advanced venous leg ulcers caused by chronic venous insufficiency (CVI).

Agilis Robotics Limited has announced its fund-raising status, as well as its latest technological achievements.

Laxxon Medical Corp. announced that the United States Patent and Trademark Office has issued U.S. Patent 11,419,824 B2 for the controlled administration of one or more active pharmaceutical ingredients within a drug delivery system via oral dosage forms.

Insulet Corporation, the global leader in tubeless insulin pump technology with its Omnipod® brand of products, announced plans to release its financial results for the third quarter of 2022 on November 3, 2022 after the close of the financial markets.

Design Therapeutics, Inc. reported that João Siffert, M.D., president and chief executive officer, and Sean Jeffries, Ph.D., chief operating officer, will participate in a fireside chat during the 2022 Jefferies Cell and Genetic Medicine Summit on Thursday, September 29, 2022, at 10:00 a.m. ET in NYC.